Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Scholar Rock Holding Corporation(SRRK) | 6,897,652 | 6,897,652 | 0 | $339.09M | $379.37M | 31.16% | +$40.28M |
| Alumis Inc | 6,345,219 | 6,345,219 | 0 | $139.79M | $178.55M | 14.67% | +$38.77M |
| Mineralys Therapeutics, Inc.(MLYS) | 5,871,018 | 5,871,018 | 0 | $159.05M | $158.40M | 13.01% | -$645.8K |
| Septerna, Inc.(SEPN) | 3,149,128 | 3,149,128 | 0 | $75.67M | $105.46M | 8.66% | +$29.79M |
| Alamar Biosciences Inc | 0 | 2,480,310 | +2,480,310 | $0 | $67.19M | 5.52% | +$67.19M |
| Neurogene Inc.(NGNE) | 1,717,127 | 1,717,127 | 0 | $34.62M | $54.00M | 4.44% | +$19.39M |
| Kalaris Therapeutics, Inc.(KLRS) | 12,948,081 | 12,881,175 | -66,906 | $74.71M | $52.43M | 4.31% | -$22.28M |
| SpyGlass Pharma, Inc.(SGP) | 2,109,953 | 2,109,953 | 0 | $54.67M | $46.97M | 3.86% | -$7.70M |
| Sutro Biopharma, Inc.(STRO) | 1,062,872 | 1,062,872 | 0 | $26.48M | $35.29M | 2.90% | +$8.81M |
| Inventiva S.A.ADS(IVA) | 5,194,805 | 6,314,805 | +1,120,000 | $28.83M | $23.87M | 1.96% | -$4.96M |
| Jade Biosciences Inc | 968,798 | 736,237 | -232,561 | $13.61M | $16.36M | 1.34% | +$2.75M |
| Parabilis Medicines Inc | 0 | 556,044 | +556,044 | $0 | $15.22M | 1.25% | +$15.22M |
| vTv Therapeutics Inc.CL A(VTVT) | 298,496 | 298,496 | 0 | $11.84M | $11.24M | 0.92% | -$600.0K |
| Aquestive Therapeutics Inc | 2,500,000 | 2,500,000 | 0 | $10.38M | $10.40M | 0.85% | +$25.0K |
| Nkarta, Inc.(NKTX) | 3,507,666 | 3,507,666 | 0 | $7.40M | $9.93M | 0.82% | +$2.53M |
| Artiva Biotherapeutics, Inc.(ARTV) | 0 | 954,861 | +954,861 | $0 | $9.26M | 0.76% | +$9.26M |
| Rani Therapeutics Holdings, Inc.CL A(RANI) | 8,500,000 | 10,369,159 | +1,869,159 | $6.25M | $7.88M | 0.65% | +$1.64M |
| AgomAb Therapeutics NVADS(AGMB) | 600,000 | 600,000 | 0 | $6.29M | $7.79M | 0.64% | +$1.49M |
| ABIVAX Société AnonymeADS(ABVX) | 56,581 | 55,095 | -1,486 | $6.30M | $7.34M | 0.60% | +$1.04M |
| X4 Pharmaceuticals, Inc.(XFOR) | 1,832,566 | 1,395,587 | -436,979 | $7.57M | $6.52M | 0.54% | -$1.05M |
| Eloxx Pharmaceuticals Inc | 0 | 400,000 | +400,000 | $0 | $5.55M | 0.46% | +$5.55M |
| Coherus Oncology, Inc.(CHRS) | 3,428,571 | 3,428,571 | 0 | $5.79M | $4.80M | 0.39% | -$994.3K |
| Upstream Bio, Inc.(UPB) | 736,047 | 353,717 | -382,330 | $6.62M | $2.45M | 0.20% | -$4.18M |
| Gossamer Bio, Inc.(GOSS) | 7,222,559 | 7,222,559 | 0 | $2.37M | $1.19M | 0.10% | -$1.18M |
| Arcellx Inc COMMON STOCK | 60,873 | 0 | -60,873 | $6.99M | $0 | — | -$6.99M |
| Palvella Therapeutics, Inc.(PVLA) | 38,432 | 0 | -38,432 | $4.79M | $0 | — | -$4.79M |